Note: This document contains side effect information about cysteamine. Some dosage forms listed on this page may not apply to the brand name Procysbi.
Summary
Common side effects of Procysbi include: lethargy, vomiting, and anorexia. Other side effects include: skin rash. Continue reading for a comprehensive list of adverse effects.
Applies to cysteamine: oral capsule, oral capsule delayed release, oral packet.
Serious side effects of Procysbi
Along with its needed effects, cysteamine (the active ingredient contained in Procysbi) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking cysteamine:
More common
- Diarrhea
- drowsiness
- fever
- loss of appetite
- nausea
- skin rash
- stomach pain
- vomiting
Less common
- Confusion
- dizziness
- headache
- mental depression
- sore throat
- trembling
Rare
- Increased thirst
- seizures
- unusual tiredness or weakness
Incidence not known
- Blistering, peeling, or loosening of the skin
- blurred or double vision
- bone lesions
- bulging soft spot on the head of an infant
- change in the ability to see colors, especially blue or yellow
- chills
- continuing ringing or buzzing or other unexplained noise in the ears
- cough
- eye pain
- hearing loss
- itching
- joint or muscle pain
- loss of appetite
- loss of bowel control
- loss of vision
- pain behind the eyes
- pain in the legs
- pain with eye movement
- red skin lesions, often with a purple center
- red, irritated eyes
- reddish purple lines on the arms, face, legs, trunk, or groin
- severe headache
- sores, ulcers, or white spots in the mouth or on the lips
Other side effects of Procysbi
Some side effects of cysteamine may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Less common
- Breath odor
- constipation
- hives
- redness of the skin
- unusual drowsiness, dullness, tiredness, weakness, or feeling of sluggishness
- weight loss
For Healthcare Professionals
Applies to cysteamine: oral capsule, oral delayed release capsule, oral granule enteric coated.
General
The most common adverse events were vomiting, abdominal pain, nausea, anorexia, fever, diarrhea, lethargy, headache, and rash.[Ref]
Gastrointestinal
Very common (10% or more): Vomiting (35%), diarrhea (16%)
Common (1% to 10%): Nausea, bad breath, abdominal pain, dyspepsia
Uncommon (0.1% to 1%): Gastrointestinal ulceration and bleeding, constipation, gastroenteritis, duodenitis[Ref]
Metabolic
Very common (10% or more): Anorexia (31%)
Uncommon (0.1% to 1%): Dehydration[Ref]
Nervous system
Very common (10% or more): Lethargy (11%)
Common (1% to 10%): Dizziness, headache, encephalopathy
Uncommon (0.1% to 1%): Somnolence, seizures, convulsions, ataxia, confusion, tremor, hyperkinesia, jitteriness
Postmarketing reports: Benign intracranial hypertension with papilledema[Ref]
Other
Very common (10% or more): Fever (22%)
Common (1% to 10%): Fatigue, asthenia
Uncommon (0.1% to 1%): Decreasing hearing[Ref]
Dermatologic
Cases of Ehlers-Danlos like syndrome and vascular disorders on elbows have been reported in children chronically treated with high doses of different cysteamine (the active ingredient contained in Procysbi) preparations. In cases where histopathological examination of the skin was performed, the results suggested angioendotheliomatosis.[Ref]
Common (1% to 10%): Rash, skin odor
Uncommon (0.1% to 1%): Hair color changes, skin fragility (molluscoid pseudomotor on elbows)
Frequency not reported: Urticaria
Postmarketing reports: Skin lesions, skin striae, skin fragility[Ref]
Hepatic
Common (1% to 10%): Abnormal liver function
Frequency not reported: Elevated alkaline phosphatase[Ref]
Cardiovascular
Uncommon (0.1% to 1%): Hypertension[Ref]
Genitourinary
Uncommon (0.1% to 1%): Abnormal urine odor[Ref]
Hematologic
Uncommon (0.1% to 1%): Leukopenia, anemia[Ref]
Immunologic
Uncommon (0.1% to 1%): Anaphylactic reaction[Ref]
Musculoskeletal
Uncommon (0.1% to 1%): Joint hyperextension, leg pain, genu valgum, osteopenia, compression fracture, scoliosis
Postmarketing reports: Molluscoid pseudotumors[Ref]
Psychiatric
Uncommon (0.1% to 1%): Nervousness, abnormal thinking, depression, emotional lability, hallucinations, nightmares[Ref]
Renal
Uncommon (0.1% to 1%): Nephrotic syndrome, interstitial nephritis, renal failure[Ref]
Cases of nephrotic syndrome have been reported within 6 months of starting therapy with progressive recovery after treatment discontinuation. In some cases, histology showed a membranous glomerulonephritis of the renal allograft and hypersensitivity interstitial nephritis.[Ref]
